Zylox-Tonbridge Medical Technology Co., Ltd. announced unaudited consolidated earnings results for the six months ended June 30, 2021. For the period, the company reported revenue of RMB 71,484,000 compared to RMB 2,108,000 a year ago. Operating loss was RMB 71,914,000 compared to RMB 34,433,000 a year ago. Loss and total comprehensive loss for the period attributable to the equity holders of the company was RMB 69,717,000 compared to RMB 34,800,000 a year ago. Basic and diluted loss per share was RMB 0.27 compared to RMB 0.19 a year ago.